The research, led by L. J. Getz, A. L. Qian, Vivian Liu and colleagues, focused on a central challenge in phage biology: how bacteria detect viral DNA when that DNA has been chemically modified to evade immune surveillance. Many phages alter their genomes by replacing standard nucleobases or adding chemical groups to them. These modifications can protect viral DNA from restriction enzymes and other bacterial defences, but they also create unusual molecular patterns. The new findings show that bacteria can exploit those patterns through specialized DNA glycosylases that selectively recognize modified bases in phage genomes.

DNA glycosylases are best known as components of DNA repair pathways. In conventional repair, a glycosylase scans DNA and identifies a damaged or chemically altered base, then cleaves the bond connecting that base to the sugar-phosphate backbone. This generates an abasic site, which can subsequently be processed by additional repair enzymes. By removing the abnormal base rather than cutting the DNA backbone directly, glycosylases provide a precise mechanism for correcting chemical damage while limiting unnecessary disruption to the chromosome.

The study shows that some members of this enzyme class have been repurposed for antiviral defence. Using structure-guided discovery, the researchers identified two widespread families of anti-phage glycosylases, named Dag1 and Dag2. Although these proteins are related to the broader DNA glycosylase fold, their biological role is distinct from routine repair. Dag1 and Dag2 act as immune effectors that preferentially target phage DNA containing modified guanine bases, allowing bacteria to distinguish invading genomes from their own unmodified genetic material.

This selectivity is important because a defence enzyme that indiscriminately damaged every chemically unusual base could also threaten the host chromosome. Phage genomes, however, may carry modifications that are rare or absent in bacterial DNA. By recognizing these non-canonical forms of guanine, Dag1 and Dag2 can focus their activity on viral DNA during infection. The resulting base removal is expected to produce lesions that compromise the integrity or replication of the phage genome, thereby reducing the virus’s ability to generate progeny.

Rather than relying solely on sequence comparisons, the researchers used the conserved three-dimensional architecture of glycosylases as a guide for finding additional defence proteins. This approach allowed them to search for structurally related enzymes that may have diverged so extensively at the sequence level that conventional genome-mining methods would overlook them. The resulting collection included numerous defence-associated glycosylases, suggesting that the antiviral use of this fold is not limited to Dag1 and Dag2 but represents a broad and diverse evolutionary strategy.

The diversity of these enzymes also points to a wider chemical contest between bacteria and phages. Phages are known to deploy an array of modified bases, including altered guanine and thymidine derivatives, to make their DNA resistant to bacterial nucleases and other immune mechanisms. In response, bacteria appear to have evolved glycosylases with different molecular specificities. The newly described systems collectively form a repertoire capable of targeting chemically modified phage DNA, potentially matching the variety of base modifications found across viral lineages.

The researchers further identified a distinct glycosylase superfamily associated with protection against phages carrying modified thymidine bases. Its separation from the Dag1 and Dag2 families indicates that bacteria have recruited more than one structural solution to the same broad problem: detecting and neutralizing viral genomes that contain non-standard nucleobases. The discovery expands the known functional range of glycosylases and illustrates how common biochemical frameworks can be adapted to recognize chemically distinct targets.

These findings have implications beyond the specific defence systems described in the study. Bacterial genomes contain many proteins whose functions remain unknown, particularly among rapidly evolving defence islands enriched in genes involved in phage resistance. Structure-guided analysis may reveal immune functions that are invisible to sequence-based annotation, helping researchers map the hidden architecture of bacterial antiviral biology. The work also underscores the evolutionary flexibility of DNA repair enzymes, which can be redeployed from preserving genetic information to attacking an invading genome.

As phage therapy, synthetic biology and microbiome research continue to develop, understanding these mechanisms could become increasingly important. Bacterial glycosylases may influence which phages can infect particular hosts, while phage base modifications may determine whether an infection succeeds or fails. The study establishes DNA glycosylases as a versatile class of bacterial immune proteins and demonstrates that the molecular signatures created by phage genome modification can become liabilities. In the continuing conflict between bacteria and viruses, chemical camouflage may therefore provide protection—but it can also reveal the invader to a precisely adapted cellular defence.

Subject of Research: Antiviral DNA glycosylases that recognize and damage chemically modified phage DNA.

Article Title: Antiviral defence is a conserved function of diverse bacterial DNA glycosylases

Article References: Getz, L.J., Qian, A.L., Vivian Liu, Y. et al. Antiviral defence is a conserved function of diverse bacterial DNA glycosylases. Nature Microbiology (2026). https://doi.org/10.1038/s41564-026-02441-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41564-026-02441-0

Keywords: Bacteriophages, bacterial immunity, DNA glycosylases, modified DNA bases, phage defence, Dag1, Dag2, antiviral defence, genome modification, microbial evolution

Central to this newly described mechanism is the interplay between a trypsin-like protease and an MBL nuclease. The study, led by Huang, Liu, Guo, and colleagues, delves deeply into the Hachiman-associated trypsin–MBL system, elucidating how protease-mediated activation underpins bacterial antiviral responses. Contrary to previous assumptions that bacterial immune effectors operate independently, this work highlights a remarkable level of regulatory complexity orchestrated through proteolytic activation and nucleotide sensing. Their findings illuminate how bacteria maintain a delicate balance between robust antiviral defense and self-preservation, avoiding the pitfalls of auto-toxicity.

The trypsin domain associated with HamAB, a component of the Hachiman system, exhibits unique regulatory features unprecedented in bacterial proteases. The study reveals that this protease is inhibited by ATP under resting conditions, a surprising discovery given the general notion that ATP often serves as an energy source or an activator in cellular processes. Here, ATP functions as a negative regulator, maintaining the protease in an inactive conformation until the detection of foreign genetic material—a clever molecular safeguard preventing spontaneous activation that could damage the host.

Further structural investigations demonstrated that MBL, the nucleus-like effector, exists in an autoinhibited state. Two insertion loops physically obstruct its catalytic site, rendering the nuclease inactive. This structural autoinhibition safeguards bacterial DNA from unintended cleavage, ensuring that the destructive enzymatic activity of MBL only commences upon a concrete signal. This finding exemplifies the sophisticated evolutionary mechanisms bacteria have developed to mitigate self-harm while deploying potent antiviral weapons.

Upon phage infection, the trypsin•HamAB complex engages with foreign DNA, triggering ATP hydrolysis and subsequent activation of its protease function. This activation unleashes the trypsin-like domain, which specifically targets and cleaves the insertion loops on the MBL domain. By removing this autoinhibitory barrier, the nuclease becomes fully competent to degrade DNA, exerting an antiviral effect by depleting viral genetic material. This cascade ultimately inhibits bacterial cell growth, a controlled sacrifice mechanism to curb phage propagation within the population.

These mechanistic insights were dramatically advanced through cutting-edge cryo-electron microscopy (cryo-EM) studies. The team captured the trypsin•HamAB complex bound to DNA, revealing how DNA binding and ATP hydrolysis provoke large-scale conformational rearrangements. The data illustrate that engagement with foreign DNA induces oligomerization of HamAB and the liberation of the trypsin-like domain from its inhibited state. This allosteric activation exemplifies an elegant regulatory architecture where molecular sensing and proteolytic function are seamlessly integrated.

The multidimensional regulatory controls that safeguard this system underscore the evolutionary importance of preventing self-toxicity—one of the central challenges in immune defense. The complex avoids accidental activation by requiring a precise combination of signals, including DNA recognition and nucleotide hydrolysis. Thus, the bacterial cell harnesses energetic cues and molecular interactions to delicately balance immune potency and cellular integrity, a striking parallel with eukaryotic immune regulatory pathways.

Moreover, the widespread presence of this trypsin–MBL module across diverse bacterial lineages points to its evolutionary conservation as a core antiviral mechanism. This suggests that protease-mediated activation of nucleases may represent a fundamental strategy within the bacterial “immune repertoire,” akin to the proteolytic cascades observed in animal innate immunity. The discovery broadens current conceptual frameworks around microbial defense, emphasizing the role of regulated proteolysis beyond canonical restriction-modification systems or CRISPR-Cas pathways.

Functionally, the identification and characterization of this module open exciting avenues for biotechnological applications. Understanding how protease activation triggers nuclease function in a controlled manner might inspire novel antimicrobial strategies or synthetic biology tools designed to mimic or manipulate bacterial immune systems. Such insights could be leveraged to engineer bacteria with enhanced phage resistance or to develop novel antiviral agents targeting structurally analogous systems in pathogenic microbes.

This research also prompts a reevaluation of the interplay between nucleotide signaling and proteolytic activation in microbial immunity. The unique inhibitory role of ATP in the trypsin•HamAB complex may reflect a broader regulatory paradigm where metabolic states influence immune readiness. Future investigations into how cellular energy dynamics intersect with immune activation could reveal additional layers of control and feedback within bacterial defense networks.

In conclusion, the work by Huang et al. significantly advances our molecular understanding of bacterial antiviral immunity by unveiling a conserved trypsin–MBL protease-nuclease module. This discovery not only enriches our knowledge of microbial defense strategies but also highlights the exquisite regulatory precision bacteria employ to mitigate viral threats. Through a compelling combination of biochemical assays and high-resolution structural analyses, this study showcases the power of proteolytic activation as a switch that converts latent nucleases into lethal antiviral effectors, all while ensuring self-preservation through multilayered control mechanisms.

Such findings emphasize that bacterial immune systems are far more intricate than previously appreciated, employing sophisticated molecular architectures that parallel higher organisms. As we continue to dissect these natural defense systems, the potential to harness or disrupt them for therapeutic and industrial applications grows exponentially. The identification of this widespread trypsin–MBL system marks a pivotal advance, setting the stage for future explorations into the dynamic proteolytic regulation underpinning bacterial immunity.

As we unravel the molecular choreography of trypsin and MBL domains, it becomes clear that proteolysis is not merely a destructive process but a critical regulatory mechanism enabling targeted immune responses. The study showcases how nature masters control over potent enzymatic activities, ensuring they are unleashed only under precisely defined pathological circumstances. Such insights offer a blueprint to engineer synthetic immune circuits or develop novel antimicrobial agents that mimic these natural regulatory strategies.

This discovery also resonates beyond the microbiological realm, with implications for understanding protease-nuclease coupling in eukaryotic innate immunity, where proteolytic cascades activate effectors to counteract infections. The conserved nature of regulatory proteolysis across life forms hints at deep evolutionary roots and underscores the universality of protease-based immune regulation. As researchers explore these commonalities, interdisciplinary breakthroughs bridging microbiology, immunology, and structural biology are poised to transform our comprehension of host-pathogen interactions.

Ultimately, the delineation of this widespread trypsin–MBL module crystallizes a vivid example of evolution’s resourcefulness, revealing how bacteria ingeniously harness molecular specificity and proteolytic activation to mount effective defenses against the relentless pressure of viral predation. This sophisticated immune strategy highlights the continuous molecular arms race shaping life at the microscopic scale and propels the frontiers of microbial immunology into an exciting new era.

Subject of Research: Bacterial antiviral immune mechanisms involving trypsin–MBL protease-nuclease modules.

Article Title: The antiphage mechanism of a widespread trypsin–MBL defense module.

Article References:
Huang, P., Liu, J., Guo, L. et al. The antiphage mechanism of a widespread trypsin–MBL defense module. Nat Chem Biol (2026). https://doi.org/10.1038/s41589-026-02252-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41589-026-02252-8